X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (927) 927
Book Review (119) 119
Publication (92) 92
Conference Proceeding (70) 70
Book Chapter (30) 30
Book / eBook (7) 7
Web Resource (4) 4
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (591) 591
humans (585) 585
hematology (388) 388
male (364) 364
female (355) 355
middle aged (340) 340
aged (294) 294
oncology (245) 245
adult (224) 224
amyloidosis (186) 186
abridged index medicus (182) 182
multiple myeloma (161) 161
prognosis (151) 151
treatment outcome (139) 139
aged, 80 and over (130) 130
survival (125) 125
retrospective studies (123) 123
multiple-myeloma (115) 115
stem-cell transplantation (114) 114
transplantation (113) 113
primary systemic amyloidosis (111) 111
survival analysis (96) 96
medicine, general & internal (94) 94
multiple myeloma - drug therapy (88) 88
diagnosis (87) 87
therapy (87) 87
care and treatment (84) 84
chemotherapy (84) 84
amyloidosis - therapy (81) 81
al amyloidosis (80) 80
amyloidosis - diagnosis (80) 80
bortezomib (78) 78
dexamethasone (78) 78
melphalan (76) 76
survival rate (76) 76
multiple myeloma - therapy (73) 73
antineoplastic combined chemotherapy protocols - therapeutic use (70) 70
stem cell transplantation (70) 70
follow-up studies (69) 69
stem cells (69) 69
amyloidosis - mortality (64) 64
transplantation, autologous (62) 62
monoclonal gammopathy (61) 61
multiple myeloma - mortality (59) 59
antineoplastic agents - therapeutic use (58) 58
amyloidosis - complications (56) 56
disease progression (54) 54
amyloidosis - pathology (53) 53
hematopoietic stem cell transplantation (53) 53
article (52) 52
risk factors (52) 52
analysis (49) 49
multiple myeloma - diagnosis (48) 48
multiple myeloma - pathology (48) 48
high-dose melphalan (47) 47
thalidomide (46) 46
amyloidosis - drug therapy (45) 45
disease-free survival (45) 45
hematology, oncology and palliative medicine (45) 45
light-chain amyloidosis (44) 44
immunoglobulins (41) 41
biopsy (40) 40
brain natriuretic peptide (40) 40
combined modality therapy (40) 40
immunology (40) 40
recurrence (40) 40
research (40) 40
medical research (39) 39
patients (39) 39
phase-ii trial (39) 39
internal medicine (38) 38
myeloma (38) 38
patient outcomes (38) 38
cancer (36) 36
prednisone (35) 35
rituximab (35) 35
dexamethasone - administration & dosage (34) 34
lenalidomide (34) 34
thalidomide - analogs & derivatives (34) 34
undetermined significance (34) 34
cardiac & cardiovascular systems (32) 32
progression (32) 32
time factors (32) 32
amyloid (30) 30
cyclophosphamide (30) 30
cardiomyopathy (29) 29
multiple myeloma - genetics (29) 29
mutation (29) 29
waldenstrom macroglobulinemia - drug therapy (29) 29
amyloidosis - immunology (28) 28
cardiac amyloidosis (28) 28
immunoglobulin light chains - blood (28) 28
immunoglobulin light chains - metabolism (28) 28
melphalan - therapeutic use (28) 28
staging system (28) 28
high-dose therapy (27) 27
immunoglobulin light chains (27) 27
risk (27) 27
thalidomide - therapeutic use (27) 27
trial (27) 27
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Haematology, ISSN 0007-1048, 09/2010, Volume 150, Issue 6, pp. 647 - 662
Journal Article
Journal Article
1999, Hematology/oncology clinics of North America, Volume 13, no. 6., xv, p. 1117-1384
Book
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2019, Volume 74, Issue 3, pp. 296 - 298
Transthyretin (TTR) is the protein responsible for the transportation of thyroxine and retinol-binding protein in the circulation. It is a 55-kDa protein... 
heart failure | amyloidosis | AG10 | cardiomyopathy | transthyretin | ATTR-CM | DIFLUNISAL | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIAC AMYLOIDOSIS | Heart failure | Proteins | Biopsy | Cardiomyopathy | Liver | Transthyretin | FDA approval | Mutation | Patients | Drug dosages | Quality of life
Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2017, Volume 177, Issue 5, pp. 669 - 671
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 02/2019, pp. 1 - 2
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2018, Volume 36, Issue 27, pp. 2749 - 2751
Journal Article
American Journal of Hematology, ISSN 0361-8609, 09/2018, Volume 93, Issue 9, pp. 1169 - 1180
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 11/2018, Volume 59, Issue 11, pp. 2521 - 2523
Journal Article
Blood Cancer Journal, ISSN 2044-5385, 07/2019, Volume 9, Issue 7, pp. 1 - 1
An amendment to this paper has been published and can be accessed via a link at the top of the paper. 
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 07/2019, Volume 94, Issue 7, pp. 1380 - 1381
Because his diarrhea was not improving, he began taking adalimumab, which is an anti-tumor necrosis factor a (TNF-a) agent, and received a total of 80 mg... 
MEDICINE, GENERAL & INTERNAL | TNF-ALPHA THERAPY | DISEASE | Advanced glycosylation end products | Diarrhea | Glycosylation | Arthritis | Tumor necrosis factor-α | Macrophages | Patients | Inflammatory diseases | Abdomen | Inflammatory bowel disease | Interleukin 6 | Proteins | Pain | Stem cells | Monoclonal antibodies | Tumor necrosis factor-TNF | Amyloid | Amyloidosis
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 02/2018, Volume 186, p. 170
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 02/2018, Volume 186, p. 170
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 02/2018, Volume 186, pp. 170 - 170
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 05/2019, Volume 60, Issue 6, pp. 1349 - 1351
Journal Article
American Journal of Hematology, ISSN 0361-8609, 02/2017, Volume 92, Issue 2, pp. 209 - 217
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 02/2018, Volume 186, p. 170
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.